Halozyme Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.
HALO Key Statistics
Stock Snapshot
Halozyme Therapeutics(HALO) stock is priced at $101.78, giving the company a market capitalization of 12.58B. It carries a P/E multiple of 29.59.
On 2026-08-07, Halozyme Therapeutics(HALO) stock moved within a range of $89.00 to $102.02. With shares now at $101.78, the stock is trading +14.4% above its intraday low and -0.2% below the session's peak.
Trading activity shows a volume of 5.52M, compared to an average daily volume of 1.8M.
Over the past 52 weeks, Halozyme Therapeutics(HALO) stock has traded between a high of $102.02 and a low of $61.23.
Over the past 52 weeks, Halozyme Therapeutics(HALO) stock has traded between a high of $102.02 and a low of $61.23.
HALO News
Halozyme Therapeutics stock has delivered a 106.2% return over the past five years, yet the current valuation checks lean toward the shares looking rich on mark...
Reports Q2 revenue $481M, consensus $402.28M. “We delivered another quarter of strong performance, with multiple proof points demonstrating the attractive featu...
Analyst ratings
82%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.